ArticleHistochemistry and cell biology2015
c-Jun N-terminal kinase inhibitor SP600125 enhances barrier function and elongation of human pancreatic cancer cell line HPAC in a Ca-switch model.
Takumi Konno et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it